Search is Powered by Google
Breast Cancer News

Breast Cancer Treatment Disparities Between Black, White Women In Georgia Exist Despite Health Insurance Status, Study Finds

Main Category: Breast Cancer
Also Included In: Health Insurance / Medical Insurance
Article Date: 03 Jun 2008 - 10:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:4 and a half stars

4.5 (2 votes)

Article Opinions: 0 posts

Black women in Georgia newly diagnosed with breast cancer are less likely to receive adequate health care treatment than whites even when they have health insurance, according to a study presented on Sunday at the annual meeting of the American Society of Clinical Oncology in Chicago, the Atlanta Journal-Constitution reports. The study was conducted by HealthCore, a research subsidiary of WellPoint and led by Louise Short, director of HealthCore's Integrated Research Network, and Otis Brawley, chief medical officer of the American Cancer Society. The study aimed to determine why black women have an increased risk of breast cancer and death from the disease.

Researchers analyzed claims data and medical charts of more than 3,000 Blue Cross and Blue Shield of Georgia beneficiaries who were diagnosed with breast cancer between January 2000 and August 2005. BCBS is the parent company of WellPoint. The researchers found several factors that predicted worse outcomes for blacks, including being diagnosed at a younger age and later stage and having a lower prevalence of hormone-positive breast cancer, lower rates of hormone therapy for certain patients and higher prevalence of hypertension.

For years, researchers were under the impression that a lack of health insurance in part contributed to black women's breast cancer disparities, but the study "data shows that while health insurance is an important predictor of the quality of care an individual receives, it's not the only factor," Brawley said. He added that many black women might "not trust the system" and delay seeking treatment.

The study says that "culturally sensitive and targeted interventions must be developed to increase earlier detection of breast cancer in [blacks], increase the percentage of patients that receive hormonal therapy when it is indicated and include management of co-morbid conditions." Brawley said, "[W]e must work to improve care and outcomes among this population" (Hendrick, Atlanta Journal-Constitution, 6/2).

An abstract of the study is available online.

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

Breast Cancer Treatment: Get Involved image Breast Cancer Treatment: Get Involved

Today, breast cancer patients may be treated by a multidisciplinary team of specialists, consisting of nurses, oncologists, surgeons, social workers, nutritionists and genetic counselors. However, patients, too, have a critical role in their treatment...

View more videos...